Subscribe to Money Morning get daily headlines subscribe now! Money Morning Private Briefing today's private briefing

Impax Labs Inc (NASDAQ: IPXL)

$13.50 USD $0.15 (1.12%)
Last Price $13.5
Net Change $0.15 (1.12%)
Bid $0
Ask Price $0
Open Price $13.3
Previous Close Price $13.35
High Price $13.55
Low Price $12.7
Number of Trades 8,884
Volume 1,863,800
Fifty Two Week High $37.2 (2016-04-22)
Fifty Two Week Low $7.75 (2017-03-07)
Average Daily Volume 2,010,647
Share Outstanding 73,810 Shares
Total Dividend Payout 0/yr
Dividend Yield 0%
1st Quarter Earnings $0.16 (2017-03-01)
2nd Quarter Earnings $0.37 (2016-11-09)
3nd Quarter Earnings $0.21 (2016-08-09)
4th Quarter Earnings $0.43 (2016-05-10)
PE Ratio $11.41
EPS Growth $-34.48
Recent Earnings $0.16
Annual EPS $1.17
Last Quarter EPS $
Market Capitalization $1.00B
Insider Shareholders % 0.033%
Annual Revenue $0B
No. Shares Outstanding 73,810
Inst. Shareholder % 81.29%
Annual Net Income $0B
TTM Net Profit Margin $111.28
1-Year Return -62.76%
3-Year Return -48.61%
5-Year Return -43.7%
5-Year Revenue Growth 60.73%
5-Year Earnings Growth 19.59%
5-Year Dividend Growth 0%
Annual Dividend $0
Annual Dividend Yield 0%
Change in EPS YTD -34.48%
Dividends per Share $
Stock Split Ratio
Beta 1.24
Impax Laboratories, Inc. is a technology-based, specialty pharmaceutical company engaged in the development, manufacture, and marketing of specialty prescription pharmaceutical products utilizing its own formulation expertise and drug delivery technologies. IMPAX Laboratories is focusing on two key areas, namely Generic Pharmaceutical Products and Branded Pharmaceutical Products. In the generic pharmaceuticals market, it focuses its efforts on controlled-release generic versions of selected brand-name pharmaceuticals covering a range of therapeutic areas. In the brand-name pharmaceuticals market, Impax is developing products for the treatment of central nervous system disorders. The company sells its products to large pharmaceutical wholesalers, warehousing chain drug stores, mass merchandisers, and mail-order pharmacies through strategic alliances and the company's global pharmaceuticals division.

IPXL News & Stock Updates